Six Years in Prison for Over-prescribing Adderall

July 10, 2026by Chris Aiken, MD0

This advertisement was part of the evidence the DOJ used to convict the Done team

They wrote the Adderall scripts as fast as their EMR would allow them

NEWS UPDATE: Department of Justice Conviction

On July 7, 2026, a federal judge sentenced Ruthia He (pronounced “Huh”), founder and former CEO of Done Global, to six years in prison and a $1 million fine for running a scheme that flooded the country with more than 37 million Adderall pills. David Brody, the company’s former clinical president, got two years and the same fine.

Done marketed itself as a fast, subscription-based path to an ADHD diagnosis and stimulant refills, spending $40 million on ads that often featured young people “discovering” they had the disorder. The company paid clinicians up to $60,000 a month to sign prescriptions every 30 seconds and fired clinicians who resisted. Done served more than 100,000 patients, including 6,500 that David Brody signed stimulants for without examining.

Highlights from the trial:

  • Done removed screening questions for other disorders because they caused “too much friction” for customers.
  • Dr. Brody compared stimulants to candy and a virtual holiday party, congratulating clinicians for giving them out like “Santa Claus.”
  • Ruthia He described Done as a “drug business” she hoped would become a billion-dollar “unicorn,” saying that Facebook and TikTok also profit from addiction.
  • Done used a subscription model ($79-200 per month) to minimize follow-up appointments. One clinician said it was his “dream job” to make money without seeing or talking to patients.

As investigators closed in, Ruthia He moved operations to China, deleted records, and researched countries without extradition treaties.

Patients with conditions known to worsen on stimulants, like bipolar disorder and psychosis, received ongoing refills.

Eight other people have pleaded guilty in the case. Another start-up, Cerebral, paid a $3.6 million penalty in 2024 for similar conduct.

—Chris Aiken, MD
Director, Psych Partners
Editor in Chief, Carlat Psychiatry Report

What’s Your Take? Share in Comments

Leave a Reply

Your email address will not be published. Required fields are marked *